Patients' characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry.
Yusuke EntaMasaki MiyasakaMasataka TaguriNorio TadaMasaki HataYusuke WatanabeToru NaganumaMasahiro YamawakiFutoshi YamanakaShinichi ShiraiHiroshi UenoKazuki MizutaniMinoru TabataKensuke TakagiMasanori YamamotoKentaro Hayashidanull nullPublished in: Open heart (2021)
Em-TAVR was performed in 5.4% of patients. Higher CFS, PAD, hypoalbuminaemia, reduced LVEF and preprocedural MR predicted the need for Em-TAVR. Em-TAVR was not a predictor for mortality in the multivariate analysis, suggesting that it is a reasonable treatment option.
Keyphrases
- transcatheter aortic valve replacement
- aortic stenosis
- aortic valve
- ejection fraction
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- transcatheter aortic valve implantation
- heart failure
- type diabetes
- magnetic resonance
- cardiovascular events
- risk factors
- coronary artery disease
- cardiovascular disease
- patient reported
- data analysis
- smoking cessation